NCT Number: NCT00429390
Effect of Fasting With Two Meals on Insulin Resistance Indices of Metabolic Syndrome
this study was conducted to assess the insulin resistance indices in the subjects undergoing Ramadan fasting (diet which consisted of two meals at 12 hours intervals)for a thirty days period.
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
Male
Study type
Interventional
Phase
Not applicable
About this study
Insulin resistance is a feature of a number of clinical disorders, including type 2 diabetes/glucose intolerance, obesity, dyslipidaemia and hypertension clustering in the so-called metabolic syndrome.The prevalence of the metabolic syndrome, as defined by the 2001 ATP III criteria, was 22 percent, with an age-dependent increase.Data demonstrates that the prevalence has continued to increase, particularly in women.Hyperinsulinemia occurring in response to insulin resistance may play an important role in the genesis of metabolic syndrome. Prevention or reduction of obesity, particularly abdominal obesity, is the main therapeutic goal in patients with the metabolic syndrome .Weight reduction is optimally achieved with a multimodality approach including diet, exercise, and possible pharmacologic therapy, as with orlistat .It has been shown that many different diets such as Mediterranean diet, DASH diet, Foods with low glycemic index and low saturated fat diet, independent of weight loss, by reducing insulin resistance may be effective in improving the metabolic syndrome .During the month of Ramadan (The ninth month of the Islamic calendar), Muslims fast every day from dawn to sunset. They refrain from drinking and eating for about 12h intervals. There are currently no reports on the effect of Ramadan fasting (only two meals per day) on metabolic syndrome. Therefore, this study was conducted to assess the insulin resistance indices in the subjects undergoing this type of fasting for a thirty days period.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Males with metabolic syndrome
Exclusion criteria
Conditions with insulin resistance including:
- Type 2 diabetes mellitus
- Infections
- Stresses
- Uremia
- Acromegaly
- Glucocorticoid excess
- Hypertension
- Cirrhosis and;
- Any addiction or drug therapy
Treatment and study plan
Primary outcomes
-
Measuring insulin sensitivity in metabolic syndrome
Sponsors and collaborators
Lead sponsor
Free Islamic University of Medical Sciences
Other
Registry information
Important dates
- Study start
- 2006
- Study completion
- 2006
- First posted
- Jan 31, 2007
- Registry last updated
- Jan 31, 2007
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Modified Huanglian Wendan Decoction for Metabolic Syndrome
NCT07702669
Glucose Metabolism Disorders, Hyperinsulinism
Harbin, Heilongjiang, China
View Trial DetailsPolyamine Treatment in Elderly Patients With Coronary Artery Disease
NCT06186102
Arterial Occlusive Diseases, Arteriosclerosis
Aarhus, Jutland, Denmark
View Trial DetailsFMT in Obesity: RYGB vs. LEAN vs. Autologous FMT
NCT06268990
Body Weight, Diabetes
Graz, Austria
View Trial DetailsSerum Adipokines and Metabolic Parameters With Hormone Replacement in Newly Diagnosed Hypothyroidism
NCT07616570
Arachnodactyly, Congenital Abnormalities
Istanbul, Turkey (Türkiye)
View Trial Details